Novel GLP-1 Drug on Attack Path Against Very High Triglycerides

MedPage Today) — NEW ORLEANS — An investigational triple-receptor agonist made some headway in patients with severe hypertriglyceridemia, a phase II study showed.
One Chinese cohort had triglycerides slashed from around 800 mg/dL at baseline…